PRKG1 Gene
Overview <table class="infobox infobox-gene">
PRKG1 (Protein Kinase cGMP-Dependent 1) encodes the cyclic GMP-dependent protein kinase 1 (PKG1), a serine/threonine kinase that mediates the effects of cyclic GMP (cGMP) on various cellular processes. PKG1 is a key effector of the nitric oxide (NO)-cGMP signaling pathway and plays important roles in neuronal function, synaptic plasticity, and cardiovascular regulation. Dysregulation of PKG1 signaling has been implicated in multiple neurodegenerative conditions.
Protein Structure and Function PKG1 exists in two alternatively spliced isoforms:
PKG1α : Higher affinity for cGMP, predominant in cerebellumPKG1β : Lower cGMP affinity, more widely expressed [@pkg]...
PRKG1 Gene
Overview <table class="infobox infobox-gene">
PRKG1 (Protein Kinase cGMP-Dependent 1) encodes the cyclic GMP-dependent protein kinase 1 (PKG1), a serine/threonine kinase that mediates the effects of cyclic GMP (cGMP) on various cellular processes. PKG1 is a key effector of the nitric oxide (NO)-cGMP signaling pathway and plays important roles in neuronal function, synaptic plasticity, and cardiovascular regulation. Dysregulation of PKG1 signaling has been implicated in multiple neurodegenerative conditions.
Protein Structure and Function PKG1 exists in two alternatively spliced isoforms:
PKG1α : Higher affinity for cGMP, predominant in cerebellumPKG1β : Lower cGMP affinity, more widely expressed [@pkg]The protein consists of:
N-terminal regulatory domain with cGMP binding sites
Catalytic kinase domain
Dimerization domain
Signaling Pathway PKG1 is activated by binding of cGMP, which relieves autoinhibition and activates the kinase domain. Key activators include:
Nitric oxide (NO) → soluble guanylate cyclase (sGC) → cGMP [@nocgmppkg]
Atrial natriuretic peptide (ANP) → particulate guanylate cyclase → cGMP
cGMP analogs (8-Br-cGMP, 8-pCPT-cGMP)
Neuronal Functions In [neurons](/entities/neurons), PKG1 regulates:
Synaptic plasticity : PKG is required for [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and long-term depression (LTD) [@pkga]Gene expression : Phosphorylates transcription factors including CREBIon channel function : Modulates [NMDA receptor](/entities/nmda-receptor) activity and calcium channelsDendritic spine morphology : Regulates spine formation and maintenance [@pkg2003]Axon guidance : Controls growth cone dynamicsDisease Associations
Alzheimer's Disease Multiple lines of evidence link PKG1 dysregulation to AD pathogenesis:
Amyloid-β effects : [Aβ](/proteins/amyloid-beta) oligomers impair NO-cGMP signaling, reducing PKG1 activation and contributing to synaptic dysfunction [@amyloidbeta2009][Tau](/proteins/tau) pathology : PKG1 can phosphorylate tau, potentially affecting its aggregation and toxicity [@pkgb]Memory deficits : PKG inhibitors impair memory, while PKG activators enhance cognitive function [@pkg2013]
Parkinson's Disease PKG1 signaling is altered in PD models and may affect:
Dopaminergic neuron survival : NO-cGMP-PKG signaling influences neuronal viability [@nocgmp2012]Mitochondrial function : PKG regulates mitochondrial dynamics and biogenesis [@pkg2017]Neuroinflammation : PKG modulates microglial activation and inflammatory responses [@pkgc]Stroke and Vascular Dementia Given its role in vascular function, PKG1 is relevant to vascular cognitive impairment:
Regulates cerebral blood flow
Controls [blood-brain barrier](/entities/blood-brain-barrier) integrity
Mediates ischemic preconditioning
Therapeutic Implications PKG1 is a potential therapeutic target:
PKG activators : Cinaciguat and similar compounds for vascular cognitive impairmentPDE5 inhibitors (e.g., sildenafil): Increase cGMP levels, indirectly activating PKGNO donors : Enhance cGMP productionClinical trials are investigating PDE5 inhibitors for dementia-related cognitive decline. [@pde2017]
Research Directions Key questions remain:
How does PKG1 dysregulation contribute to specific neurodegenerative processes?
Can PKG-targeted therapies improve cognitive function in AD/PD?
What are the isoform-specific roles in neurons?
See Also
[cGMP Signaling](/mechanisms/cgmp-signaling)
[Nitric Oxide Signaling](/mechanisms/nitric-oxide-signaling)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Vascular Dementia](/diseases/vascular-dementia)
References
Unknown, PRKG1 gene overview - NCBI Gene (n.d.)
[Unknown, PKG isoforms and their functions - Pharmacol Rev (n.d.)](https://doi.org/10.1124/pr.57.2.5)
[Unknown, NO-cGMP-PKG signaling pathway - Nat Rev Neurosci (n.d.)](https://doi.org/10.1038/nrn1914)
[Unknown, PKG in synaptic plasticity - Learn Mem (n.d.)](https://doi.org/10.1101/lm.91710)
[Unknown, PKG and dendritic spine morphology - J Neurosci (2003)](https://doi.org/10.1523/JNEUROSCI.23-30.10670.2003)
[Unknown, Amyloid-beta and cGMP signaling - J Neurosci (2009)](https://doi.org/10.1523/JNEUROSCI.1572-09.2009)
[Unknown, PKG phosphorylation of tau - J Biol Chem (n.d.)](https://doi.org/10.1074/jbc.M110.160150)
[Unknown, PKG and memory - Trends Pharmacol Sci (2013)](https://doi.org/10.1016/j.tips.2013.06.008)
[Unknown, NO-cGMP in dopaminergic neurons - Antioxid Redox Signal (2012)](https://doi.org/10.1089/ars.2012.4796)
[Unknown, PKG and mitochondrial dynamics - Cell Death Discov (2017)](https://doi.org/10.1038/cddiscovery.2017.30)
[Unknown, PKG and neuroinflammation - J Neuroinflammation (n.d.)](https://doi.org/10.1186/s12974-017-0903-5)
[Unknown, PDE5 inhibitors for dementia - Nat Rev Drug Discov (2017)](https://doi.org/10.1038/nrd.2017.173) Show full description